lansoprazole and histamine

lansoprazole has been researched along with histamine in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (30.00)18.2507
2000's2 (20.00)29.6817
2010's4 (40.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
HÃ¥kanson, R; Karlsson, A; Lee, H; Mattsson, H; Sundler, F1
Inatomi, N; Nagaya, H; Satoh, H1
Araki, T; Kakinoki, B; Morinaka, Y; Takeuchi, Y; Uchiyama, K; Wakatsuki, D1
Fujiwara, K; Karasuyama, M; Murata, I; Shin, M; Tanabe, T; Ueoka, R1
Naseri, E; Yenisehirli, A1
Arikawa, Y; Hirase, K; Hori, Y; Imanishi, A; Inatomi, N; Kajino, M; Matsukawa, J; Nishida, H; Tsukimi, Y1
Hori, Y; Inatomi, N; Kajino, M; Matsukawa, J; Nishida, H; Takeuchi, T1
Hide, M; Ishii, K; Iwamoto, K; Moriwaki, M; Takahagi, S1
Chen, Y; Hou, Y; Li, H; Li, S; Lin, J; Liu, T; Ma, Y; Wang, Y; Yang, H; Zhang, X; Zhang, Y; Zhou, L; Zhou, X1

Other Studies

10 other study(ies) available for lansoprazole and histamine

ArticleYear
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Lansoprazole and omeprazole have similar effects on plasma gastrin levels, enterochromaffin-like cells, gastrin cells and somatostatin cells in the rat stomach.
    Digestion, 1992, Volume: 51, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Enterochromaffin Cells; Female; Gastric Acid; Gastrins; Histamine; Histidine Decarboxylase; Lansoprazole; Omeprazole; Parietal Cells, Gastric; Rats; Rats, Inbred Strains; Somatostatin; Stomach

1992
Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
    Japanese journal of pharmacology, 1991, Volume: 55, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Bethanechol Compounds; Dogs; Famotidine; Female; Gastric Acid; Gastric Mucosa; Histamine; Hydrogen-Ion Concentration; Lansoprazole; Male; Omeprazole; Pentagastrin; Peptones; Pylorus; Rats; Rats, Inbred Strains

1991
The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
    The Journal of pharmacy and pharmacology, 1999, Volume: 51, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Analgesics, Non-Narcotic; Animals; Anti-Ulcer Agents; Carbachol; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gastric Acid; Gastric Fistula; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Histamine; Hydrogen-Ion Concentration; Imidazoles; Lansoprazole; Male; Microsomes; Omeprazole; Proton Pump Inhibitors; Pyridines; Stomach; Tetragastrin; Time Factors

1999
Immunoelectron microscopic study for histamine in the gastric enterochromaffin-like cells of rats treated with the proton pump inhibitor lansoprazole.
    Histochemistry and cell biology, 2003, Volume: 120, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Antibodies, Monoclonal; Cytoplasm; Enterochromaffin-like Cells; Enzyme Inhibitors; Exocytosis; Histamine; Lansoprazole; Male; Microscopy, Immunoelectron; Omeprazole; Proton Pump Inhibitors; Rats; Rats, Wistar; Secretory Vesicles; Vacuoles

2003
Proton pump inhibitors omeprazole and lansoprazole induce relaxation of isolated human arteries.
    European journal of pharmacology, 2006, Feb-15, Volume: 531, Issue:1-3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Calcium; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Histamine; Humans; In Vitro Techniques; Lansoprazole; Male; Mammary Arteries; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Omeprazole; Ouabain; Phenylephrine; Potassium; Proton Pump Inhibitors; Radial Artery; Vasoconstriction; Vasoconstrictor Agents; Vasodilation

2006
1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Dithiothreitol; Gastric Acid; Gastric Mucosa; Histamine; Hydrogen-Ion Concentration; Imidazoles; In Vitro Techniques; Kinetics; Lansoprazole; Ligation; Male; Potassium; Proton Pump Inhibitors; Pylorus; Pyrroles; Rats; Rats, Sprague-Dawley; Stomach; Sulfonamides; Swine

2010
A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animals.
    The Journal of pharmacology and experimental therapeutics, 2011, Volume: 337, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Cimetidine; Dogs; Gastric Acid; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Histamine; Histamine Agonists; Hydrogen-Ion Concentration; Lansoprazole; Male; Potassium; Proton Pump Inhibitors; Pyrroles; Rats; Rats, Sprague-Dawley; Sulfonamides; Time Factors

2011
Case of anaphylaxis to lansoprazole confirmed by histamine release test and oral provocation test.
    The Journal of dermatology, 2019, Volume: 46, Issue:4

    Topics: Drug Hypersensitivity; Esophagitis, Peptic; Histamine; Histamine Release; Humans; Immunologic Tests; Lansoprazole; Middle Aged; Proton Pump Inhibitors

2019
Acid suppressants use and risk of atherosclerotic cardiovascular disease in middle-aged and older adults.
    Atherosclerosis, 2022, Volume: 358

    Topics: Aged; Antihypertensive Agents; Atherosclerosis; Cardiovascular Diseases; Histamine; Humans; Lansoprazole; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Risk Assessment; Risk Factors

2022